ArticleBMJ open2022

Study protocol for a randomised, double-blinded, placebo-controlled phase III trial examining the add-on efficacy, cost-utility and neurobiological effects of low-dose naltrexone (LDN) in patients with fibromyalgia (INNOVA study).

Ariadna Colomer-Carbonell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.